• Phare
  • Validé par KD/KO

Anticorps Polyclonal de lapin anti-ASGR1

ASGR1 Polyclonal Antibody for WB, IHC, IF-P, FC, IP, ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain, rat, souris

Applications

WB, IHC, IF-P, FC, IP, CoIP, ELISA, Blocking assay

Conjugaison

Non conjugué

N° de cat : 11739-1-AP

Synonymes

asialoglycoprotein receptor 1, HL-1, Asgpr1, ASGP-R 1, ASGPR 1



Applications testées

Résultats positifs en WBcellules HepG2, tissu hépatique de rat, tissu hépatique de souris, tissu hépatique humain
Résultats positifs en IPtissu hépatique de souris,
Résultats positifs en IHCtissu hépatique de rat, tissu de cancer du foie humain, tissu hépatique de souris
il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0.
Résultats positifs en IF-Ptissu de cancer du foie humain, tissu hépatique de rat, tissu hépatique humain
Résultats positifs en cytométriecellules HepG2,

Dilution recommandée

ApplicationDilution
Western Blot (WB)WB : 1:5000-1:50000
Immunoprécipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunohistochimie (IHC)IHC : 1:1000-1:4000
Immunofluorescence (IF)-PIF-P : 1:50-1:500
Flow Cytometry (FC)FC : 0.40 ug per 10^6 cells in a 100 µl suspension
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

11739-1-AP cible ASGR1 dans les applications de WB, IHC, IF-P, FC, IP, CoIP, ELISA, Blocking assay et montre une réactivité avec des échantillons Humain, rat, souris

Réactivité Humain, rat, souris
Réactivité citéeHumain, souris
Hôte / Isotype Lapin / IgG
Clonalité Polyclonal
Type Anticorps
Immunogène ASGR1 Protéine recombinante Ag2310
Nom complet asialoglycoprotein receptor 1
Masse moléculaire calculée 291 aa, 33 kDa
Poids moléculaire observé 38-42 kDa
Numéro d’acquisition GenBankBC032130
Symbole du gène ASGR1
Identification du gène (NCBI) 432
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par affinité contre l'antigène
Tampon de stockage PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3
Conditions de stockageStocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

Asialoglycoprotein receptor (ASGPR), also known as the hepatic galactose/N-acetylglucosamine (GlcNAc) receptor or Ashwell receptor, is a C-type lectin expressed exclusively in hepatic parenchymal cells. ASGPR consists of two subunits, a major subunit (ASGR1, HL-1) and a minor subunit (ASGR2, HL-2), and specifically recognizes terminal β-linked galactose or GlcNAc on circulating glycoproteins or cells. This receptor plays a critical role in serum glycoprotein homeostasis by mediating the endocytosis and lysosomal degradation of glycoproteins that contain terminal galactose or GlcNAc residues. ASGPR may facilitate hepatic infection by multiple viruses including hepatitis B, and is also a target for liver-specific drug delivery.

Protocole

Product Specific Protocols
WB protocol for ASGR1 antibody 11739-1-APDownload protocol
IHC protocol for ASGR1 antibody 11739-1-APDownload protocol
IF protocol for ASGR1 antibody 11739-1-APDownload protocol
IP protocol for ASGR1 antibody 11739-1-APDownload protocol
FC protocol for ASGR1 antibody 11739-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
mouseFC

Nature

Regulated control of gene therapies by drug-induced splicing.

Authors - Alex Mas Monteys
mouseFC

Nano Lett

A Potent Branched-Tail Lipid Nanoparticle Enables Multiplexed mRNA Delivery and Gene Editing In Vivo.

Authors - Khalid A Hajj
humanIF

Acta Biomater

Modeling nonalcoholic fatty liver disease on a liver lobule chip with dual blood supply.

Authors - Kun Du
humanWB

Biomaterials

Dual targeted delivery of statins and nucleic acids by chitosan-based nanoparticles for enhanced antiatherosclerotic efficacy.

Authors - Ting Jiang
humanWB

Cancer Res

ASO-Based PKM Splice-Switching Therapy Inhibits Hepatocellular Carcinoma Growth.

Authors - Wai Kit Ma
humanIHC,IF

Mol Ther

Enhanced Potency of GalNAc-Conjugated Antisense Oligonucleotides in Hepatocellular Cancer Models.

Authors - Youngsoo Kim

Avis

The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.


FH

Kamal (Verified Customer) (02-15-2024)

Mouse liver lysates were subjected to SDS PAGE followed by western blot with 11739-1-AP (ASGR1 antibody) at dilution of 1:25000 incubated at 4 degree C overnight. ASGR1 bands appeared at about 42 kDa.

  • Applications: Western Blot
  • Primary Antibody Dilution: 1:25000
  • Cell Tissue Type: Mouse liver tissue
FH

Kamal (Verified Customer) (02-15-2024)

Mouse liver lysates were subjected to SDS PAGE followed by western blot with 11739-1-AP (ASGR1 antibody) at dilution of 1:25000 incubated at 4 degree C overnight. ASGR1 bands appeared at about 42 kDa.

  • Applications: Western Blot
  • Primary Antibody Dilution: 1:25000
  • Cell Tissue Type: Mouse liver tissue
FH

James (Verified Customer) (11-18-2022)

Very good antibody! Used it to label hepatocytes in section of paraffin-embedded liver tissue

  • Applications: Immunofluorescence
  • Primary Antibody Dilution: 1/1000
  • Cell Tissue Type: Liver
ASGR1 Antibody Immunofluorescence validation (1/1000 dilution) in Liver (Cat no:11739-1-AP)